Andrew Jack

15.3k total citations · 4 hit papers
206 papers, 9.9k citations indexed

About

Andrew Jack is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Andrew Jack has authored 206 papers receiving a total of 9.9k indexed citations (citations by other indexed papers that have themselves been cited), including 127 papers in Pathology and Forensic Medicine, 60 papers in Genetics and 59 papers in Oncology. Recurrent topics in Andrew Jack's work include Lymphoma Diagnosis and Treatment (100 papers), Chronic Lymphocytic Leukemia Research (56 papers) and Viral-associated cancers and disorders (29 papers). Andrew Jack is often cited by papers focused on Lymphoma Diagnosis and Treatment (100 papers), Chronic Lymphocytic Leukemia Research (56 papers) and Viral-associated cancers and disorders (29 papers). Andrew Jack collaborates with scholars based in United Kingdom, Canada and United States. Andrew Jack's co-authors include Russell Patmore, Roger G. Owen, Sharon Barrans, Eve Roman, Gareth J. Morgan, Andy C. Rawstron, Debra Howell, Stephen J. Richards, Paul Evans and Peter Johnson and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Nucleic Acids Research.

In The Last Decade

Andrew Jack

195 papers receiving 9.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2015 611 citations Umberto Vitolo, Andrew Jack et al. profile →
Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network

2011 486 citations A. G. Smith, Debra Howell et al. profile →
Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles

2013 357 citations David Cunningham, Andrew Jack et al. profile →
Lymphoma incidence, survival and prevalence 2004–2014: sub-type analyses from the UK’s Haematological Malignancy Research Network

2015 282 citations Simon Crouch, Dan Painter et al. profile →

Peers

Countries citing papers authored by Andrew Jack

Since Specialization

Citations

This map shows the geographic impact of Andrew Jack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Jack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Jack more than expected).

Fields of papers citing papers by Andrew Jack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Jack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Jack. The network helps show where Andrew Jack may publish in the future.

Co-authorship network of co-authors of Andrew Jack

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Jack. A scholar is included among the top collaborators of Andrew Jack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Jack. Andrew Jack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Time to Surgery Following Complete Cervical Spinal Cord Injury: Evolution of Clinical Practice Patterns Over a Decade from 2010 to 2020 Across North American Trauma Centers 2024 ·Journal of Neurotrauma ·(unknown), Husain Shakil, Armaan K. Malhotra, Jetan H. Badhiwala, (unknown), (unknown), Andrew Jack, François Mathieu, Avery B. Nathens, (unknown), Christopher D. Witiw	0
2	Evolution of Real-World Clinical Practice in Time to Surgery Following Thoracolumbar Spinal Cord Injury: An Observational Study of North American Trauma Centers from 2010 to 2020 2024 ·Journal of Neurotrauma ·(unknown), Armaan K. Malhotra, Husain Shakil, Jetan H. Badhiwala, (unknown), (unknown), (unknown), Andrew Jack, François Mathieu, Jefferson R. Wilson, Christopher D. Witiw	0
3	Characterization of Spinal Cord Injury Patients for Arm Functional Restoration through Nerve Transfer 2023 ·Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques ·Andrew Jack, (unknown), Christopher D. Witiw, (unknown), Jaret L. Olson, Michael Morhart, Line Jacques, K. Ming Chan	0
4	The Modified Iliac Screw: An Anatomic Comparison and Technical Guide 2020 ·World Neurosurgery ·Alexander von Glinski, Emre Yilmaz, Basem Ishak, Erik Hayman, Wyatt L. Ramey, Andrew Jack, Joe Iwanaga, Rod J. Oskouian, R. Shane Tubbs, Jens R. Chapman	6
5	Malignant triton tumor in the setting of segmental neurofibromatosis: A rare case report and review of the literature 2020 ·SHILAP Revista de lepidopterología ·Andrew Jack, Christopher D. Witiw, Aaron Hockley, (unknown), Rosanna Wustrack, Line Jacques	1
6	Neurovascular Relations in Modified Iliac Screws and Traditional Iliac Screw: Anatomic Study 2019 ·World Neurosurgery ·Alexander von Glinski, Emre Yilmaz, Basem Ishak, Wyatt L. Ramey, Andrew Jack, Joe Iwanaga, Amir Abdul-Jabbar, Rod J. Oskouian, R. Shane Tubbs, Jens R. Chapman	5
7	Effects of Regular Coke and Coke Zero on Blood Glucose, Serum Lipid Profile and Activities of Serum Aminotransferases in Healthy Human Subjects 2015 ·International Journal of Science and Research (IJSR) ·(unknown), (unknown), Andrew Jack, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
8	Determinants of survival in patients with chronic myeloid leukaemia treated in the new era of oral therapy: findings from a UK population-based patient cohort 2014 ·BMJ Open ·A. G. Smith, Dan Painter, Debra Howell, Paul Evans, Graeme Smith, Russell Patmore, Andrew Jack, Eve Roman	42
9	Addition of Rituximab to Chlorambucil Produces Superior Event-Free Survival in the Treatment of Patients With Extranodal Marginal-Zone B-Cell Lymphoma: 5-Year Analysis of the IELSG-19 Randomized Study 2013 ·Journal of Clinical Oncology ·Emanuele Zucca, Annarita Conconi, Daniele Laszlò, Armando López‐Guillermo, Réda Bouabdallah, Bertrand Coiffier, Catherine Sebban, Fabrice Jardin, Umberto Vitolo, Franck Morschhauser, Stefano Pileri, Christiane Copie‐Bergman, Elı́as Campo, Andrew Jack, Irene Floriani, Peter Johnson, Maurizio Martelli, Franco Cavalli, Giovanni Martinelli, Catherine Thiéblemont	148
10	FcRL5 as a Target of Antibody–Drug Conjugates for the Treatment of Multiple Myeloma 2012 ·Molecular Cancer Therapeutics ·Kristi Elkins, Bing Zheng, MaryAnn Go, Dionysos Slaga, Changchun Du, Suzie J. Scales, Shang‐Fan Yu, Jacqueline McBride, Ruth de Tute, Andy C. Rawstron, Andrew Jack, Allen Ebens, Andrew G. Polson	69
11	FoRT: A Phase 3 Multi-Center Prospective Randomized Trial of Low Dose Radiation Therapy for Follicular and Marginal Zone Lymphoma 2012 ·International Journal of Radiation OncologyBiologyPhysics ·Peter Hoskin, Amy A. Kirkwood, (unknown), Caroline Brammer, Patricia Díez, Martin Robinson, Isabel Syndikus, Andrew Jack, Paul D. Smith	4
12	Rearrangement of MYC Is Associated With Poor Prognosis in Patients With Diffuse Large B-Cell Lymphoma Treated in the Era of Rituximab 2010 ·Journal of Clinical Oncology ·Sharon Barrans, Simon Crouch, Alex Smith, Kathryn Turner, Roger G. Owen, Russell Patmore, Eve Roman, Andrew Jack	402
13	Randomized Comparison of the Stanford V Regimen and ABVD in the Treatment of Advanced Hodgkin's Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244 2009 ·Journal of Clinical Oncology ·Peter Hoskin, Lisa Lowry, Alan Horwich, Andrew Jack, (unknown), Barry W. Hancock, Paul Smith, Wendi Qian, (unknown), Bilyana Popova, Andrew R. Pettitt, David Cunningham, Ruth Pettengell, John Sweetenham, David C. Linch, Peter Johnson	124
14	The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research 2009 ·British Journal of Haematology ·Alexandra Smith, Eve Roman, Debra Howell, Richard A. Jones, Russell Patmore, Andrew Jack	111
15	Efficient mitochondrial targeting relies on co-operation of multiple protein signals in plants 2008 ·Journal of Experimental Botany ·Laurent Châtre, Loren A. Matheson, Andrew Jack, Sally L. Hanton, Federica Brandizzí	12
16	Organisation of neoplastic haematopathology services: a UK perspective 2005 ·Pathology ·Andrew Jack	5
17	An international multi-centre, randomized, open-label, phase III trial comparing rituximab added to CVP chemotherapy to CVP chemotherapy alone in untreated stage III/IV follicular non-Hodgkins lymphoma. 2003 ·Ghent University Academic Bibliography (Ghent University) ·Robert Marcus, Kevin Imrie, Andrew Belch, David Cunningham, (unknown), J. Catalano, P. Solal-Céligny, Fritz Offner, Jan Walewski, (unknown), Andrew Jack, Philip N. Smith	34
18	NAT2 Acetylator Genotypes Confer No Effect on the Risk of Developing Adult Acute Leukemia 2001 ·Cancer Epidemiology and Prevention Biomarkers ·Sara Rollinson, Philippa L. Roddam, Eleanor V. Willett, Eve Roman, Ray A. Cartwright, Andrew Jack, Gareth J. Morgan	1
19	The lymphoproliferative disorders : handbook of diagnosis, investigation and management 1998 ·J. A. Child, Andrew Jack, Gareth J. Morgan	5
20	A phase 1 study to address the safety and efficacy of granulocyte colony‐stimulating factor for the mobilization of hematopoietic progenitor cells in active rheumatoid arthritis 1997 ·Arthritis & Rheumatism ·Dennis McGonagle, Andy C. Rawstron, Stephen J. Richards, John D. Isaacs, Howard Bird, Andrew Jack, Gareth J. Morgan, Paul Emery	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact